What People Get Wrong About IV Ketamine Therapy: Addressing Common Misconceptions at Healing and Psychiatry in Flagstaff, AZ
As interest in ketamine-based treatments for mental health conditions continues to grow in 2026, so does the amount of misinformation surrounding these therapies. At Healing and Psychiatry in Flagstaff, AZ, we hear questions and concerns from patients on a regular basis-many of them rooted in myths that can prevent people from exploring a treatment option that may genuinely help them. One of the most common areas of confusion involves the topic of ketamine IV vs. Spravato, with patients unsure about the differences, safety profiles, and what to expect from each treatment. In this post, we will walk through some of the most persistent misconceptions about IV ketamine therapy and provide clear, evidence-based information to help you make more informed decisions about your mental health care.
Myth #1: IV Ketamine and Spravato Are Basically the Same Thing
This is perhaps the single most widespread misconception we encounter. While both IV ketamine and Spravato (esketamine) are derived from the same class of medication, they are distinct treatments with different formulations, delivery methods, and clinical applications. Understanding the nuances of ketamine IV vs. Spravato is essential for anyone considering either option.
How They Differ in Formulation and Delivery
IV ketamine is the racemic form of ketamine, meaning it contains both the S-enantiomer and R-enantiomer of the molecule. It is administered intravenously in a controlled clinical setting, allowing the provider to precisely adjust dosing in real time based on each patient’s response. Spravato, on the other hand, is a nasal spray that contains only the S-enantiomer (esketamine). It was approved by the FDA in 2019 specifically for treatment-resistant depression and is administered under supervision in a certified healthcare setting.
The route of administration matters more than many people realize. Intravenous delivery allows for near-complete bioavailability, meaning nearly all of the medication reaches the bloodstream. Nasal spray absorption can vary from patient to patient due to factors like nasal congestion, technique, and individual anatomy. This distinction is one reason why some clinicians and patients prefer the precision that IV delivery offers.
Different Clinical Considerations
Another important difference lies in the range of conditions each treatment may address. Spravato carries an FDA indication specifically for treatment-resistant depression and major depressive disorder with suicidal ideation. IV ketamine, while used off-label, has been studied and used clinically for a broader range of conditions, including anxiety disorders, PTSD, OCD, and certain chronic pain syndromes. This broader potential application is part of what makes IV ketamine a compelling option for many patients who have not found relief through traditional treatments.
At Healing and Psychiatry, we take the time to help each patient understand these differences so they can have an informed conversation with their provider about which approach may be most appropriate for their individual needs.
Myth #2: Ketamine Therapy Is Unsafe or “Experimental”
Another persistent misconception is that ketamine-based therapies are dangerous, untested, or somehow fringe treatments. In reality, ketamine has been used in medicine for over five decades. It was first approved by the FDA in 1970 as an anesthetic and has been on the World Health Organization’s List of Essential Medicines for years. Its safety profile at sub-anesthetic doses-the levels used in IV ketamine therapy-has been extensively studied in clinical research.
Safety in a Clinical Setting
When administered in a supervised clinical environment like Healing and Psychiatry in Flagstaff, IV ketamine therapy involves careful medical oversight. Patients are monitored throughout the infusion for vital signs, comfort, and response. Dosing is individualized and adjusted as needed. The treatment is not self-administered, nor is it provided in uncontrolled environments. These safeguards are a critical part of what separates clinical ketamine therapy from the misconceptions that often circulate online.
It is also worth noting that while some patients may experience temporary side effects during or shortly after an infusion-such as mild dissociation, nausea, or changes in blood pressure-these effects are typically short-lived and resolve within a couple of hours. Your provider at Healing and Psychiatry will discuss potential side effects with you in detail before treatment begins.
The “Experimental” Label Is Misleading
The term “experimental” is sometimes applied to IV ketamine because its use for mental health conditions is considered off-label. However, off-label prescribing is an established and common practice across medicine. Many widely used medications are prescribed off-label based on robust clinical evidence. The growing body of research supporting ketamine’s role in mental health treatment continues to expand in 2026, with numerous peer-reviewed studies demonstrating its potential to help patients with treatment-resistant conditions.
Myth #3: IV Ketamine Only Provides Temporary Relief
Some people hesitate to pursue IV ketamine therapy because they believe the benefits are fleeting-lasting only hours or days before symptoms return entirely. While it is true that ketamine therapy is not a permanent cure for depression, anxiety, or other mental health conditions, characterizing it as merely “temporary” overlooks the full picture.
How IV Ketamine May Support Lasting Change
Research has shown that ketamine may promote neuroplasticity-the brain’s ability to form new neural connections. This mechanism is believed to be part of why many patients experience improvement in mood and thought patterns following a series of infusions. Rather than simply masking symptoms, IV ketamine may help create an environment in the brain that supports more lasting therapeutic change, particularly when combined with ongoing psychotherapy and other evidence-based treatments.
Most treatment protocols involve an initial series of infusions followed by maintenance sessions as needed. The frequency and duration of maintenance vary from person to person. Some patients report sustained improvement for weeks or months between sessions. Others may benefit from more frequent follow-up. At Healing and Psychiatry, treatment plans are tailored to each individual, with regular assessments to determine the most effective schedule.
The Importance of a Comprehensive Approach
IV ketamine therapy is most effective when it is part of a broader treatment plan. This might include medication management, therapy, lifestyle modifications, and other supportive interventions. Patients who approach IV ketamine as one component of their overall mental health strategy tend to experience the most meaningful and sustained benefits. No single treatment-whether medication, therapy, or ketamine-works in isolation for most people.
Myth #4: Ketamine Therapy Is Only for People Who Have “Tried Everything Else”
There is a common belief that ketamine-based treatments should only be considered as a last resort after every other option has been exhausted. While IV ketamine is often associated with treatment-resistant depression, the reality is more nuanced than that.
Many patients who seek treatment at Healing and Psychiatry have tried multiple medications and therapies without adequate relief. For these individuals, IV ketamine may offer a new pathway forward. However, the decision about when to consider ketamine therapy is one that should be made collaboratively between a patient and their provider, based on the individual’s clinical history, current symptoms, and treatment goals.
When patients come to us weighing their options around ketamine IV vs. Spravato, we encourage them to have an open conversation about their experiences and preferences. There is no universal threshold of “failed treatments” that must be met before ketamine therapy can be considered. What matters most is whether it is clinically appropriate for the individual patient.
Myth #5: All Ketamine Clinics Offer the Same Experience
Not all ketamine providers operate the same way, and the quality of the clinical experience can vary significantly. Some patients assume that the treatment is so standardized that it does not matter where they receive it. This is simply not the case.
What Sets a Quality Practice Apart
Factors that distinguish a reputable ketamine provider include the credentials and experience of the clinical team, the level of individualized care provided, the monitoring protocols in place during treatment, and the integration of follow-up care. At Healing and Psychiatry, serving patients in Flagstaff and surrounding communities across northern Arizona, these elements are central to our approach.
We believe that the clinical environment matters just as much as the medication itself. A comfortable, supportive setting staffed by experienced professionals can make a meaningful difference in how patients respond to and experience their treatment. When people research the differences between ketamine IV vs. Spravato, we encourage them to also consider the quality and philosophy of the practice providing the treatment-not just the type of medication being administered.
Personalized Care in Flagstaff
Flagstaff residents deserve access to high-quality mental health care that is both evidence-informed and deeply personal. At Healing and Psychiatry, we take time to understand each patient’s unique circumstances, answer their questions thoroughly, and develop a treatment approach that aligns with their individual needs and goals. This personalized model of care is something we take seriously, and it is reflected in every aspect of the patient experience.
Moving Past Misconceptions Toward Informed Decisions
Misconceptions about IV ketamine therapy can create unnecessary barriers for people who might genuinely benefit from this treatment. Whether the confusion involves the differences between ketamine IV vs. Spravato, concerns about safety, or assumptions about who qualifies for treatment, the best antidote to misinformation is education and open dialogue with a qualified provider.
At Healing and Psychiatry, we are committed to providing transparent, honest information about what IV ketamine therapy can and cannot do. We do not promise instant or guaranteed results, but we do offer a treatment option that has been shown to help many patients who have struggled to find relief through conventional approaches. Our goal is to empower you with the knowledge you need to make the best decision for your mental health.
If you are in Flagstaff, AZ, and have been curious about IV ketamine therapy-or if you have questions about whether it might be appropriate for your situation-we encourage you to reach out to Healing and Psychiatry to schedule a consultation. Our team is here to listen, answer your questions, and help you explore your options in a supportive, professional environment.